Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2026-03-18 00:00:00 ET · period of report 2026-03-16 · accession 0001712276-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-18 | 2026-03-17 | RXRX | Taylor Ben R | CFO | S - Sale | $3.39 | -7,956 | 1.18M | -0.7% | -$27.0K | |
| 2026-03-18 | 2026-03-16 | RXRX | Taylor Ben R | CFO | F - Tax | $3.42 | -7,075 | 1.19M | -0.6% | -$24.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-03-17 | S | D | 7,956 | $3.39 | 1,180,318 | D | — | — | |
| 2 | Common | Class A Common Stock | 2026-03-16 | F | D | 7,075 | $3.42 | 1,188,274 | D | — | — |